Utility of the TKA postoperative additional nerve block

Utility of the TKA postoperative additional nerve block - Utility of the TKA postoperative additional nerve block

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000032405

Enrollment

Registered

2018-05-01

Start date

2018-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis of the knee joint

Interventions

additional femoral nerve block 20 ml of 0.25% levobupivacaine is injected from an indwelling catheter two days after surgery no additional femoral nerve block

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: OA knee joint planning primary TKA

Exclusion criteria

Exclusion criteria: simultaneous bilateral case the case with the limit for medication

Design outcomes

Primary

Measure	Time frame
Pain VAS (0, 3, 6, 9, 12, 24, 36, 48h) Postoperative pain-killer use The days required for SLR Change of the knee flexion angle Frequency of the adverse event	—

Countries

Japan

Contacts

Public ContactTomohiro Ojima

Fukui General Hospital Dept. of Orthopaedic Surgery

ojima@ka2.so-net.ne.jp0776-59-1300

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026